IDENTIFYING UNDERUTILISED MOLECULES|PAUL RENNIE,MANAGING DIRECTOR,Paradigm Biopharmaceuticals Ltd 00:10:00
Mr Rennie is recognised as a leading authority in drug development and has been involved in a number of pre-clinical and clinical trial programs over his accomplished career. He was the inaugural COO of Mesoblast and most recently as Executive VP, New Product Development at Mesoblast Ltd. Mr. Rennie has extensive experience in commercialising Intellectual Property.
